Study on Nano Drug Particles in the Diagnosis and Treatment of Alzheimer’s Disease in the Elderly

Objective. To study the clinical effect of nano drug particles in the diagnosis and treatment of Alzheimer’s disease in the elderly, we promote the research on the treatment of Alzheimer’s disease and provide basis. Methods. 80 patients with Alzheimer’s disease treated in our hospital from April 202...

Full description

Saved in:
Bibliographic Details
Main Authors: ChangQing Li, Yu Xiang, Yunqian Wang, Ping Li
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Bioinorganic Chemistry and Applications
Online Access:http://dx.doi.org/10.1155/2022/3335581
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552902198034432
author ChangQing Li
Yu Xiang
Yunqian Wang
Ping Li
author_facet ChangQing Li
Yu Xiang
Yunqian Wang
Ping Li
author_sort ChangQing Li
collection DOAJ
description Objective. To study the clinical effect of nano drug particles in the diagnosis and treatment of Alzheimer’s disease in the elderly, we promote the research on the treatment of Alzheimer’s disease and provide basis. Methods. 80 patients with Alzheimer’s disease treated in our hospital from April 2021 to April 2022 were selected as the research objects and were divided into the reference group and the observation group by random number table method. The reference group was given traditional treatment drugs, and the observation group was given nano drug particles. The treatment effect, blood lipid level, cognitive function status, and comprehensive effective rate of the two groups were compared, and the treatment data of the patients were scored by ADL and MMSE scale to understand the intelligence level and daily living ability of the patients. Results. From the comparison results, it is found that the blood lipid level of the control group was in the normal range. The cognitive function of the control group was also better than that of the reference group. The scores of ADL and MMSE in the control group were higher than those in the reference group. The effective rate of the control group was also higher than that of the reference group; P<0.05, with statistical significance. Conclusion. In the diagnosis and treatment of Alzheimer’s disease in the elderly, nano drug particles have good stability and less toxic and side effects, improve the ability of daily living of patients, and have good clinical treatment effect, which is worthy of clinical application.
format Article
id doaj-art-2cee8a1623174c16b3e8af1a2e79fa04
institution Kabale University
issn 1687-479X
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Bioinorganic Chemistry and Applications
spelling doaj-art-2cee8a1623174c16b3e8af1a2e79fa042025-02-03T05:57:30ZengWileyBioinorganic Chemistry and Applications1687-479X2022-01-01202210.1155/2022/3335581Study on Nano Drug Particles in the Diagnosis and Treatment of Alzheimer’s Disease in the ElderlyChangQing Li0Yu Xiang1Yunqian Wang2Ping Li3Department of Laboratory MedicineDepartment of Laboratory MedicineDepartment of Laboratory MedicineDepartment of Laboratory MedicineObjective. To study the clinical effect of nano drug particles in the diagnosis and treatment of Alzheimer’s disease in the elderly, we promote the research on the treatment of Alzheimer’s disease and provide basis. Methods. 80 patients with Alzheimer’s disease treated in our hospital from April 2021 to April 2022 were selected as the research objects and were divided into the reference group and the observation group by random number table method. The reference group was given traditional treatment drugs, and the observation group was given nano drug particles. The treatment effect, blood lipid level, cognitive function status, and comprehensive effective rate of the two groups were compared, and the treatment data of the patients were scored by ADL and MMSE scale to understand the intelligence level and daily living ability of the patients. Results. From the comparison results, it is found that the blood lipid level of the control group was in the normal range. The cognitive function of the control group was also better than that of the reference group. The scores of ADL and MMSE in the control group were higher than those in the reference group. The effective rate of the control group was also higher than that of the reference group; P<0.05, with statistical significance. Conclusion. In the diagnosis and treatment of Alzheimer’s disease in the elderly, nano drug particles have good stability and less toxic and side effects, improve the ability of daily living of patients, and have good clinical treatment effect, which is worthy of clinical application.http://dx.doi.org/10.1155/2022/3335581
spellingShingle ChangQing Li
Yu Xiang
Yunqian Wang
Ping Li
Study on Nano Drug Particles in the Diagnosis and Treatment of Alzheimer’s Disease in the Elderly
Bioinorganic Chemistry and Applications
title Study on Nano Drug Particles in the Diagnosis and Treatment of Alzheimer’s Disease in the Elderly
title_full Study on Nano Drug Particles in the Diagnosis and Treatment of Alzheimer’s Disease in the Elderly
title_fullStr Study on Nano Drug Particles in the Diagnosis and Treatment of Alzheimer’s Disease in the Elderly
title_full_unstemmed Study on Nano Drug Particles in the Diagnosis and Treatment of Alzheimer’s Disease in the Elderly
title_short Study on Nano Drug Particles in the Diagnosis and Treatment of Alzheimer’s Disease in the Elderly
title_sort study on nano drug particles in the diagnosis and treatment of alzheimer s disease in the elderly
url http://dx.doi.org/10.1155/2022/3335581
work_keys_str_mv AT changqingli studyonnanodrugparticlesinthediagnosisandtreatmentofalzheimersdiseaseintheelderly
AT yuxiang studyonnanodrugparticlesinthediagnosisandtreatmentofalzheimersdiseaseintheelderly
AT yunqianwang studyonnanodrugparticlesinthediagnosisandtreatmentofalzheimersdiseaseintheelderly
AT pingli studyonnanodrugparticlesinthediagnosisandtreatmentofalzheimersdiseaseintheelderly